HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Verastem, Inc. (VSTM)
1.67  -0.01  (-0.6%) 07-03 16:52
Open: 1.69 High: 1.7
Pre.close: 1.68 Low: 1.65
Volume: 3,122,322 Ave vol: 7,976,357
52w High: 4.67 52w Low: 0.83
MA(50): 1.809 MA(200): 2.076
EPS: -1.793 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.verastem.com
Market Cap (M): 271
Shares Out (M): 163
Verastem, Inc., a biopharmaceutical company, focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma (FL) after at least two prior systemic therapies. The indication in FL is approved under accelerated approval based on overall response rate. In addition, it is developing the focal adhesion kinase inhibitor defactinib, which is being investigated in combination with immunotherapeutic agents for the treatment of various different cancer types, including pancreatic cancer, ovarian cancer, non-small cell lung cancer (NSCLC), mesothelioma, and other solid tumors. Verastem, Inc.
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bearish
KDJ: Bullish RSI: Bearish
Target 1: 2.14 Target 2: 2.30
Resist 1: 1.84 Resist 2: 1.97
Support 1: 1.62 Support 2: 1.35
Company key metrics
Revenue per Share: 0.2341
Net Income per Share: -2.0007
Cash per Share: 0.5835
Book Value per Share: 0.0962
Price to Sales: 7.6475
Price to Book Value: 18.6081
Earnings Yield: -1.1177
Dividend Yield: 0
Debt to Equity: 19.2183
Debt to Assets: 0.9505
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Tue, 23 Jun 2020
Hedge Funds Never Loved Verastem Inc (VSTM) More - Yahoo Finance

Tue, 30 Jun 2020
Verastem, Inc. (VSTM) Fundamental and Technical Analysis Explained - The News Heater

Tue, 23 Jun 2020
Buy or Sell Verastem, Inc. (VSTM) Stock Now? Don't Try to Be a Top Gun - The News Heater

Tue, 16 Jun 2020
Verastem, Inc. (VSTM) Plans and Analysts Expectations - The News Heater

Thu, 18 Jun 2020
Is Verastem Inc (VSTM) Stock a Good Buy on Thursday? - InvestorsObserver

Wed, 10 Jun 2020
Do Institutions Own Verastem, Inc. (NASDAQ:VSTM) Shares? - Simply Wall St

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.